Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) <i>Pseudomonas aeruginosa</i>: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs

• Hauptverfasser: Marianna Meschiari (Verfasst von), Gabriella Orlando (Verfasst von), Shaniko Kaleci (Verfasst von), Vincenzo Bianco (Verfasst von), Mario Sarti (Verfasst von), Claudia Venturelli (Verfasst von), Cristina Mussini (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2021-10-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

A retrospective case-control study was conducted at Modena University Hospital from December 2017 to January 2019 to identify risk factors and predictors of MDR/XDR <i>Pseudomonas aeruginosa</i> (PA) isolation with resistance to ceftazidime/avibactam (CZA) and ceftolozane/tazobactam (C/T...